2m 2m 2m 2m 2m 2m 2m
NovoCure NPV (NVCR)
NASDAQ
$17.36+$0.25 (+1.49%)
Price as of Aug 21, 2026 7:33 PM EDT- $1.9BMarket Cap
- 37.57%1-Year Change
- Medical DevicesIndustry
NovoCure NPV (NVCR)
$17.36+$0.25 (+1.49%)
NVCR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.10 | ||
Change | -$0.67 (-3.77%) | ||
Open | $17.75 | ||
High | $17.82 | ||
Low | $17.01 | ||
Previous Close | $17.77 | ||
Volume | 1,404,005 | ||
30-Day Average Volume | 1,836,532 | ||
1-Week Change | 0.88% | ||
1-Month Change | 6.88% | ||
1-Year Change | 37.57% | ||
3-Year Change | -45.10% | ||
5-Year Change | -87.09% | ||
Fundamentals | |||
Shares Outstanding | 111.5M | ||
Total Assets | $795.2M | ||
Market Cap | $1.9B | ||
Enterprise Value | $2.0B | ||
Period: QTR TTM FY | |||
Revenue | $183.6M | ||
Net Income | -$15.7M | ||
Free Cash Flow | $1.2M | ||
EBIT | -$10.6M | ||
EBITDA | -$6.3M | ||
Net Working Capital | $417.8M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -321 | ||
Enterprise Value/Revenue | 11 | ||
P/B | 6 | ||
P/E | -132 | ||
PEG | -2 | ||
Price/Free Cash Flow | 1,568 | ||
Price/Operating Cash Flow | 234 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue